tiprankstipranks
Advertisement
Advertisement

RZLT Stock Latest News

Rezolute price target raised to $10 from $4 at Maxim
The FlyRezolute price target raised to $10 from $4 at Maxim
14d ago
RZLT
Rezolute: Buy Rating Reaffirmed as Analyst Keeps $5 Price Target on Pipeline Momentum and Phase 3 Data
PremiumRatings
Rezolute: Buy Rating Reaffirmed as Analyst Keeps $5 Price Target on Pipeline Momentum and Phase 3 Data
15d ago
RZLT
Rezolute reports Q3 EPS (16c), consensus (17c)
PremiumThe Fly
Rezolute reports Q3 EPS (16c), consensus (17c)
15d ago
RZLT
Rezolute Shares Expanded Phase 3 sunRIZE Data With FDA
PremiumCompany Announcements
Rezolute Shares Expanded Phase 3 sunRIZE Data With FDA
23d ago
8K
RZLT
Rezolute Buy Rating Reiterated as CGM Data Offset Phase 3 Miss; $5 Price Target Maintained
PremiumRatings
Rezolute Buy Rating Reiterated as CGM Data Offset Phase 3 Miss; $5 Price Target Maintained
24d ago
RZLT
Rezolute presents results from Phase 3 sunRIZE study of ersodetug at PES 2026
PremiumThe FlyRezolute presents results from Phase 3 sunRIZE study of ersodetug at PES 2026
27d ago
RZLT
Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
Premium
The Fly
Midday Fly By: Merck to acquire Terns, Arm CPU launch applauded
2M ago
GM
AMD
Wedbush upgrades Rezolute as worst case scenario seems unlikely for cHI
Premium
The Fly
Wedbush upgrades Rezolute as worst case scenario seems unlikely for cHI
2M ago
RZLT
Rezolute upgraded to Outperform from Neutral at Wedbush
PremiumThe Fly
Rezolute upgraded to Outperform from Neutral at Wedbush
2M ago
RZLT
Rezolute Prepares FDA Submission After sunRIZE Trial Review
PremiumCompany Announcements
Rezolute Prepares FDA Submission After sunRIZE Trial Review
2M ago
8K
RZLT
Rezolute provides update on sunRIZE study following Type B meeting with FDA
PremiumThe Fly
Rezolute provides update on sunRIZE study following Type B meeting with FDA
2M ago
RZLT
Rezolute management to meet with Maxim
PremiumThe Fly
Rezolute management to meet with Maxim
3M ago
RZLT
Rezolute: Positive Risk‑Reward Outlook Despite sunRIZE Miss, Backed by Encouraging Hyperinsulinism Data and Solid Cash Position
PremiumRatingsRezolute: Positive Risk‑Reward Outlook Despite sunRIZE Miss, Backed by Encouraging Hyperinsulinism Data and Solid Cash Position
3M ago
RZLT
Rezolute reports Q2 EPS (22c), consensus (18c)
Premium
The Fly
Rezolute reports Q2 EPS (22c), consensus (18c)
3M ago
RZLT
RZLT Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
RZLT Earnings this Week: How Will it Perform?
4M ago
RZLT
Rezolute price target raised to $2 from $1 at Wedbush
PremiumThe Fly
Rezolute price target raised to $2 from $1 at Wedbush
5M ago
RZLT
Maintaining a Buy on Rezolute: Clear Drug Activity, High-Need Patient Benefit, and Upcoming FDA Catalysts Support Attractive Risk-Reward
PremiumRatings
Maintaining a Buy on Rezolute: Clear Drug Activity, High-Need Patient Benefit, and Upcoming FDA Catalysts Support Attractive Risk-Reward
5M ago
RZLT
Rezolute (RZLT): Mixed Phase 3 Data, Regulatory Uncertainty in Congenital HI, and Tumor HI Optionality Support Reiterated Hold Rating
PremiumRatings
Rezolute (RZLT): Mixed Phase 3 Data, Regulatory Uncertainty in Congenital HI, and Tumor HI Optionality Support Reiterated Hold Rating
5M ago
RZLT
Rezolute: Favorable Risk-Reward on Ersodetug Despite Mixed sunRIZE Data, Supported by Biomarkers, Breakthrough Designation, and Phase 3 Potential
PremiumRatings
Rezolute: Favorable Risk-Reward on Ersodetug Despite Mixed sunRIZE Data, Supported by Biomarkers, Breakthrough Designation, and Phase 3 Potential
5M ago
RZLT
Rezolute shares findings from Expanded Access Program in tumor HI
PremiumThe FlyRezolute shares findings from Expanded Access Program in tumor HI
5M ago
RZLT
Rezolute shares observations from Phase 3 sunRIZE study in congenital HI
Premium
The Fly
Rezolute shares observations from Phase 3 sunRIZE study in congenital HI
5M ago
RZLT
Rezolute Updates sunRIZE Phase 3 Trial and FDA Plans
Premium
Company Announcements
Rezolute Updates sunRIZE Phase 3 Trial and FDA Plans
5M ago
8K
RZLT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >